M&A Expertise InterPharmaLink specializes in mergers and acquisitions, partnering, enterprise development and operational improvement for global healthcare companies, backed by a senior team and long industry track record; ideal for deal origination, due diligence and post-merger integration services—opportunity to offer tailored, tech-enabled transaction support.

Healthcare Network Serves pharma, biotech, generics and biosimilars, as well as development, manufacturing and logistics providers and PE/VC investors; potential for cross-segment cross-sell in regulatory, supply chain optimization, quality/compliance, and digital transformation services.

Growth Opportunities Small-to-mid-sized firm with modest current revenue (sub-million) and a lean team; potential to scale with scalable, affordable solutions such as CRM, marketing automation, deal-management software, or consulting service bundles tailored for growth-stage healthcare advisory firms.

Tech Enablement Current tech stack is modest and generic; may be receptive to modern collaboration, data analytics or secure document exchange tools to support complex deals and client engagements, representing a route to upsell platform or security-focused services.

Global Reach Basel-based with a claimed global healthcare client base; can position as a cross-border advisory partner for EU/Swiss markets, regulatory intelligence, and international deal execution, opening opportunities with multinational pharma and PE networks.